Romidepsin Versus Combination of Romidepsin Plus Pralatrexate in PTCL
Stopped Study was never opened due to lack of funding
Conditions
- Lymphoma, T-Cell, Peripheral
Interventions
- DRUG: Romidepsin
- DRUG: Pralatrexate
Sponsor
Jennifer Amengual
Collaborators